Management of Native Lung Malignancy in a Lung Transplant Recipient

Sarah I. Khalil, Jairo A. Espinosa, Charles Bakhos, Cherie Erkmen, Roman Petrov

Research output: Contribution to journalArticlepeer-review


A 75-year-old male patient with a history of previous right lung transplant presented with left upper lobe squamous cell carcinoma. Endobronchial ultrasound and positron emission tomography displayed no mediastinal lymphadenopathy. A ventilation-perfusion scan displayed minimal perfusion to the native lung. Left robot-assisted lysis of adhesions, decortication, left upper lobectomy, and mediastinal lymphadenectomy were performed. The patient tolerated the procedure well. Final pathology displayed pT2a, n0, m0. Lobectomy is a safe and efficient treatment of native lung malignancy in the setting of previous lung transplant with minimally functioning native lung.

Original languageEnglish (US)
Pages (from-to)567-569
Number of pages3
JournalInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Issue number6
StatePublished - Nov 1 2022
Externally publishedYes


  • lobectomy
  • lung cancer
  • lung squamous cell carcinoma
  • lung transplant
  • robotic surgery

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Management of Native Lung Malignancy in a Lung Transplant Recipient'. Together they form a unique fingerprint.

Cite this